Regulatory Situation of Herbal Medicines - A Worldwide Review
(1998; 49 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentFOREWORD
Ouvrir ce répertoire et afficher son contenuI. INTRODUCTION
Fermer ce répertoireII. REGULATORY SITUATION
Ouvrir ce répertoire et afficher son contenuAfrica
Ouvrir ce répertoire et afficher son contenuThe Americas
Ouvrir ce répertoire et afficher son contenuEastern Mediterranean
Ouvrir ce répertoire et afficher son contenuEurope
Fermer ce répertoireSouth East Asia
Afficher le documentIndia
Afficher le documentIndonesia
Afficher le documentNepal
Afficher le documentThailand
Ouvrir ce répertoire et afficher son contenuWestern Pacific
Afficher le documentIII. CONCLUSION
Afficher le documentIV. REFERENCES


Herbal medicines have to be registered by the Department of Drug Administration, at the Ministry of Health. Regulatory requirements are: manufacturing licences issued by the concerned Drug Control Authority, price approval and valid price list, letter of warranty of the manufacturer indicating his/her responsibility for safety, efficacy and quality of his products, authorization for import, export and distribution of the product, and the mode of distribution and promotion. Pharmaceutical requirements are the quantitative formula including all excipients, stability data, shelf-life, bioavailability in vitro and in vivo, wherever applicable, a description of the product including container and labelling, and a photograph of each product. For medicinal plants, permission is given by the Department of Forests [122].

vers la section précédente
vers la section suivante
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019